For research use only. Not for therapeutic Use.
Petosemtamab（Cat No.:I042193）is a monoclonal antibody that targets the protein TROP2 (trophoblast cell surface antigen 2), which is overexpressed in various cancers, including non-small cell lung cancer (NSCLC) and breast cancer. TROP2 plays a role in promoting tumor growth and metastasis. By binding to TROP2, petosemtamab aims to inhibit these processes, potentially blocking cancer cell proliferation and spreading. It is being studied in clinical trials for its safety and efficacy in treating solid tumors, with a focus on its potential as a therapeutic option for TROP2-positive cancers.
| Catalog Number | I042193 |
| CAS Number | 2213450-26-9 |
| Purity | ≥95% |
